ArticleRheumatology and therapy2022

Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials.

Lihi Eder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.